NO20032394D0 - Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft - Google Patents

Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft

Info

Publication number
NO20032394D0
NO20032394D0 NO20032394A NO20032394A NO20032394D0 NO 20032394 D0 NO20032394 D0 NO 20032394D0 NO 20032394 A NO20032394 A NO 20032394A NO 20032394 A NO20032394 A NO 20032394A NO 20032394 D0 NO20032394 D0 NO 20032394D0
Authority
NO
Norway
Prior art keywords
smarc
diagnosis
treatment
nucleic acids
prostate cancer
Prior art date
Application number
NO20032394A
Other languages
English (en)
Other versions
NO20032394L (no
Inventor
Kimberly A Gillis
Yixian Zhang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20032394D0 publication Critical patent/NO20032394D0/no
Publication of NO20032394L publication Critical patent/NO20032394L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20032394A 2000-11-28 2003-05-27 Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft NO20032394L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25348700P 2000-11-28 2000-11-28
PCT/US2001/044571 WO2002044420A2 (en) 2000-11-28 2001-11-28 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer

Publications (2)

Publication Number Publication Date
NO20032394D0 true NO20032394D0 (no) 2003-05-27
NO20032394L NO20032394L (no) 2003-07-02

Family

ID=22960480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032394A NO20032394L (no) 2000-11-28 2003-05-27 Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft

Country Status (14)

Country Link
US (1) US20020142327A1 (no)
EP (1) EP1364053A2 (no)
JP (1) JP2004527225A (no)
AU (1) AU2002227004A1 (no)
BR (1) BR0115713A (no)
CA (1) CA2429723A1 (no)
HU (1) HUP0303899A3 (no)
IL (1) IL155954A0 (no)
MX (1) MXPA03004579A (no)
NO (1) NO20032394L (no)
NZ (1) NZ526707A (no)
PL (1) PL365704A1 (no)
WO (1) WO2002044420A2 (no)
ZA (1) ZA200304995B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269557A1 (en) * 2002-10-18 2004-05-04 Lg Life Sciences Ltd. Gene families associated with cancers
US20140296248A1 (en) * 2011-04-04 2014-10-02 Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
AU2012240246A1 (en) * 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
JP7635395B2 (ja) * 2021-01-15 2025-02-25 華為技術有限公司 通信方法および装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030559A (en) * 1986-04-01 1991-07-09 Board Of Regents, The University Of Texas System Methods and compositions for the identification of metastatic human tumors
US5162504A (en) * 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5118611A (en) * 1988-07-25 1992-06-02 Adeza Biomedical Corporation Adenocarcinoma antigen binding methods and reagents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5723302A (en) * 1993-05-14 1998-03-03 Nordion International Inc. Detection of prostate-specific antigen in breast tumors
GB9309966D0 (en) * 1993-05-14 1993-06-30 Nordion Int Inc Detection of prostrate-specific antigen in breast tumors
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5976794A (en) * 1994-04-15 1999-11-02 The Trustees Of Columbia University In The City Of New York Method for molecular staging of prostate cancer
US5629007A (en) * 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) * 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
WO1997033909A2 (en) * 1996-03-15 1997-09-18 Corixa Corporation Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
CA2744096C (en) * 1996-07-31 2013-07-30 Laboratory Corporation Of America Holdings Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US5976838A (en) * 1996-12-18 1999-11-02 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999022773A2 (en) * 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO2001059094A2 (en) * 2000-02-11 2001-08-16 The Salk Institute For Biological Studies Method of regulating transcription in a cell by altering remodeling of cromatin
WO2002031209A2 (en) * 2000-10-13 2002-04-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Genes related to development of refractory prostate cancer

Also Published As

Publication number Publication date
ZA200304995B (en) 2004-09-27
JP2004527225A (ja) 2004-09-09
HUP0303899A2 (hu) 2004-03-01
US20020142327A1 (en) 2002-10-03
AU2002227004A1 (en) 2002-06-11
PL365704A1 (en) 2005-01-10
BR0115713A (pt) 2004-02-10
MXPA03004579A (es) 2003-09-04
NO20032394L (no) 2003-07-02
NZ526707A (en) 2005-03-24
WO2002044420A2 (en) 2002-06-06
HUP0303899A3 (en) 2007-05-02
CA2429723A1 (en) 2002-06-06
IL155954A0 (en) 2003-12-23
EP1364053A2 (en) 2003-11-26
WO2002044420A3 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
NO20032395D0 (no) Ekspresjonsanalyse av FKBP-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20034437L (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
AU4941101A (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
FI990559A0 (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
DE60334958D1 (de) Ultraschallsonde und Herstellungsverfahren hiervon
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1622571A4 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS CURED 109P1D4 USEFUL IN THE TREATMENT AND DETECTION OF CANCER
IT1317702B1 (it) Procedimento per l'isolamento di molecole umiche solubili in acqua eper l'ottenimento di suoi complessi con elementi chimici della
NO20032391D0 (no) Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20032393L (no) Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
EP1590437A4 (en) NUCLEIC ACIDS SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEINS NAMED 254P1D6B
NO20032394L (no) Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft
NO20020207D0 (no) Biologiske materialer og fremgangsmåter som er nyttige ved diagnostisering og behandling av sykdom
HK1057907A (en) Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1055997A (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1057237A (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
GB0128488D0 (en) Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of prostate cancer
ZA200301143B (en) Biological materials and methods useful in the diagnosis and treatment of diseases.
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases
ITNA20000012V0 (it) Macchina di analisi corporea utilizzante misurazione impedenziometrica e ultrasonica.
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
DE60035077D1 (de) In Tumoren vervielfältigte Gensequenzen und deren diagnostische Verwendungen